Susan H Fox Selected Research

Histamine H2 Antagonists

9/2014

Famotidine, a Histamine H2 Receptor Antagonist, Does Not Reduce Levodopa-Induced Dyskinesia in Parkinson's Disease: A Proof-of-Concept Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan H Fox Research Topics

Disease

88	Parkinson Disease (Parkinson's Disease) 02/2024 - 11/2002
71	Dyskinesias (Dyskinesia) 02/2024 - 11/2002
15	Parkinsonian Disorders (Parkinsonism) 01/2022 - 07/2005
15	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 09/2006
6	Dystonia (Limb Dystonia) 07/2021 - 01/2002
6	Tremor (Tremors) 10/2020 - 09/2013
4	Disease Progression 07/2022 - 01/2010
4	Hallucinations (Hallucination) 09/2017 - 11/2004
4	Chorea (Rheumatic Chorea) 09/2014 - 06/2006
3	Pain (Aches) 07/2023 - 09/2016
3	Sialorrhea 12/2020 - 11/2007
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2020 - 02/2011
3	Mood Disorders (Mood Disorder) 01/2018 - 12/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 04/2013
2	Cognitive Dysfunction 01/2019 - 05/2012
2	Hypokinesia (Bradykinesia) 03/2015 - 05/2014
1	Tauopathies 01/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2024
1	Multiple System Atrophy 01/2024
1	Myoclonus (Nocturnal Myoclonus) 09/2023
1	Stuttering (Stammering) 09/2023
1	Dysarthria (Spastic Dysarthria) 09/2023
1	Blepharospasm 11/2022
1	Torticollis (Wryneck) 07/2021
1	Epilepsy (Aura) 07/2021
1	Huntington Disease (Huntington's Disease) 01/2019
1	Intractable Pain 09/2016

Drug/Important Bio-Agent (IBA)

72	Levodopa (L Dopa)FDA LinkGeneric 02/2024 - 11/2002
28	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 11/2002
17	Dopamine (Intropin)FDA LinkGeneric 10/2020 - 07/2005
11	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 01/2008
10	Amantadine (Aman)FDA LinkGeneric 09/2023 - 11/2006
9	Clozapine (Clozaril)FDA LinkGeneric 01/2020 - 11/2006
5	Quetiapine Fumarate (Seroquel)FDA Link 01/2020 - 11/2006
5	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 11/2006
4	Dopamine Agonists (Dopamine Agonist)IBA 01/2020 - 11/2004
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 11/2007
4	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 09/2017 - 04/2010
3	Apomorphine FDA Link 10/2020 - 11/2004
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2013
3	5-HT1A Serotonin ReceptorIBA 10/2015 - 01/2012
3	Dihydroxyphenylalanine (Dopa)IBA 06/2013 - 02/2009
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2015
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 12/2020 - 10/2011
2	Rivastigmine (Exelon)FDA LinkGeneric 10/2020 - 10/2011
2	N-Methylaspartate (NMDA)IBA 11/2018 - 09/2013
2	oxidized low density lipoproteinIBA 01/2018 - 03/2013
2	Type A Botulinum Toxins (Botox)FDA Link 01/2018 - 10/2011
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2016 - 01/2015
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016 - 09/2013
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 03/2013
2	3- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA 02/2015 - 08/2012
2	Famotidine (Pepcid)FDA LinkGeneric 09/2014 - 07/2010
2	N- methyl- 1- cyclopropyl- 1- piperonylmethylamineIBA 07/2014 - 01/2012
2	Dopamine Agents (Dopaminergic Agents)IBA 09/2013 - 05/2012
2	Antidepressive Agents (Antidepressants)IBA 09/2013 - 10/2011
2	fipamezoleIBA 09/2013 - 08/2003
2	Dopamine AntagonistsIBA 06/2013 - 01/2008
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 05/2012 - 05/2011
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 05/2012 - 01/2012
2	Pergolide (Permax)FDA Link 10/2011 - 10/2011
2	Pramipexole (Mirapex)FDA LinkGeneric 10/2011 - 10/2011
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 10/2011 - 11/2007
2	nabilone (Cesamet)FDA Link 11/2002 - 01/2002
2	Cannabinoid Receptor AgonistsIBA 11/2002 - 01/2002
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2002 - 01/2002
1	Apolipoproteins E (ApoE)IBA 01/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	SynucleinsIBA 01/2024
1	Dronabinol (THC)FDA LinkGeneric 07/2023
1	CannabidiolIBA 07/2023
1	SolutionsIBA 11/2022
1	Investigational DrugsIBA 07/2022
1	perampanelIBA 07/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2021
1	AMPA Receptors (AMPA Receptor)IBA 07/2021
1	Excitatory Amino Acid AntagonistsIBA 07/2021
1	Calcium Channels (Calcium Channel)IBA 10/2020
1	pridopidineIBA 01/2019
1	ElementsIBA 01/2019
1	Capsules (Microcapsules)IBA 11/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	DPI-289IBA 01/2018
1	CannabinoidsIBA 01/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	safinamideIBA 02/2017
1	Sigma-1 ReceptorIBA 01/2017
1	Quinidine (Chinidin)FDA LinkGeneric 01/2017
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2016
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016

Therapy/Procedure

27	Therapeutics 01/2024 - 11/2006
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2017
2	Injections 01/2018 - 09/2016
2	Aftercare (After-Treatment) 01/2018 - 05/2012
2	Deep Brain Stimulation 07/2016 - 04/2011
2	Activities of Daily Living (ADL) 09/2014 - 05/2012